Alignment Healthcare, Inc. (ALHC) is a technology-first, mission-driven healthcare company dedicated to transforming the complex, highly fragmented U.S. healthcare system into a more person-centered, sustainable, value-based model. The company was founded in 2013, is headquartered in Orange, California, and is currently operating in over 22 markets across the United States. They are committed to revolutionizing the industry by leveraging advanced data analytics, proprietary technology, and a collaborative, patient-focused approach.
At the core of Alignment Healthcare's operations is a commitment to its mission: to put patients first. This is embodied in its high-touch, coordinated care model which emphasizes the importance of care continuity and coordination among all healthcare providers involved in a patient's care. The company's healthcare model seeks to enhance patients' experience and outcomes while reducing healthcare costs.
Alignment Healthcare leverages its AI-powered, proprietary technology to drive innovation in the fragmented healthcare market. Their technology platform, Alignment Intelligence System, is designed to analyze healthcare data quickly and accurately. This facilitates timely and informed decision-making, helping care providers deliver a superior healthcare experience.
A distinctive characteristic of Alignment Healthcare is its emphasis on value-based care. Value-based care, rather than fee-for-service model, is a healthcare delivery model in which providers, including hospitals and physicians, are paid based on patient health outcomes and quality of care rather than the number of services they provide. This model incentivizes healthcare providers to deliver the best care possible, improving patient outcomes while simultaneously reducing overall healthcare costs.
To further their commitment to value-based care, Alignment Healthcare has established a healthcare ecosystem composed of a network of healthcare providers, community-based resources, and home-based services. This ecosystem is designed to effectively coordinate care across different settings, from the hospital to the home, ensuring patients receive the right care at the right time.
In today’s age where patient experience, quality of care, and cost containment are paramount, Alignment Healthcare, Inc. stands as a trailblazer. Their innovative, tech-driven approach combined with their patient-first mindset continues to make a substantial impact in shaping the future of healthcare.
Income statement
Balance sheet statement
Cash flow statement
Current assets / Current liabilities
Equity / Debt / Cash
Dividends
Joseph S. Konowiecki, EVP of Corporate Affairs and Director at Alignment Healthcare, Inc. (NASDAQ:ALHC), sold 23,511 shares on September 17, 2026. This sale, at a weighted-average price of $8.61 per share, was executed solely to cover tax withholding obligations related to vested restricted stock units, not as a discretionary trade. Following the transaction, Konowiecki retains direct beneficial ownership of 1,080,305 shares.
Alignment Healthcare (ALHC) stock has significantly dropped due to concerns over Medicare Advantage reimbursement, regulatory pressures, and a whistleblower complaint alleging misclassification of expenses to inflate Adjusted EBITDA. Management's commentary on Q3 medical cost headwinds and increased second-half spending further contributed to the decline. Multiple law firms are now investigating the company for potential securities fraud, and insider selling has added to investor uncertainty.
An insider at Alignment Healthcare recently sold shares valued at $356,200, as detailed in a recent SEC filing. This transaction follows other significant insider share sales at the company in recent weeks, indicating active insider trading. Alignment Healthcare, Inc. (ALHC) operates Medicare Advantage Plans and reported its Q2 2026 earnings with revenue increases and guidance for Q3 and full-year.
Alignment Healthcare (ALHC) has experienced a significant 57% slide in its share price this year, prompting investors to scrutinize its market valuation against its earnings potential. Despite legislative changes potentially impacting Medicare Advantage margins, the company's P/E ratio of 44.4x, though higher than sector and peer averages, is considered "about right" by a fair-multiple model, suggesting the market has already factored in these risks. The article explores whether the current stock price aligns with its current and future earnings, highlighting an analyst narrative that suggests it could be significantly undervalued.
Alignment Healthcare (ALHC) shares fell 22% after executives at a Baird conference refused to discuss next year's Medicare Advantage star ratings and acknowledged higher-than-expected hospital costs. CEO John Kao cited CMS sensitivity for the silence on star ratings, while CFO Jim Head highlighted ongoing issues with institutional spending. The company attributed recent challenges to a system overhaul, though retail investor sentiment for both ALHC and Clover Health (CLOV) has risen.
Dawn Maroney, President of Alignment Healthcare, Inc. (NASDAQ:ALHC), sold 122,707 shares of company stock worth $1.55 million on September 11, 2026. These sales were mandatory to cover tax withholding obligations related to restricted stock unit vesting. The transactions occurred amid challenging market conditions for Alignment Healthcare, with the stock trading near its 52-week low despite recent positive earnings reports.